Medical Technology Stock Letter

Medical Technology Stock Letter

Financial Services, Po Box , Berkeley, , 94704, California, 40460, United States, 1-10 Employees

bioinvest.com

  • facebook
  • twitter
  • LinkedIn

Who is MEDICAL TECHNOLOGY STOCK LETTER

The Medical Technology Stock Letter (MTSL) provides solid investment advice based on company and industry fundamentals. Over twenty years of experience in providing investment advice for ...

Read More

map
  • Po Box 40460, Berkeley, California, 94704, United States Headquarters: Po Box 40460, Berkeley, California, 94704, United States
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million

industries-icon Industry: Financial Services

SIC SIC Code: 7375

checked-icon Does something look wrong? Fix it. | View contact records from MEDICAL TECHNOLOGY STOCK LETTER

Medical Technology Stock Letter Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Medical Technology Stock Letter

Answer: Medical Technology Stock Letter's headquarters are located at Po Box , Berkeley, , 94704, California, 40460, United States

Answer: Medical Technology Stock Letter's official website is https://bioinvest.com

Answer: Medical Technology Stock Letter's revenue is Under $1 Million

Answer: Medical Technology Stock Letter's SIC: 7375

Answer: Medical Technology Stock Letter has 1-10 employees

Answer: Medical Technology Stock Letter is in Financial Services

Answer: Medical Technology Stock Letter contact info: Phone number: Website: https://bioinvest.com

Answer: The Medical Technology Stock Letter (MTSL) provides solid investment advice based on company and industry fundamentals. Over twenty years of experience in providing investment advice for this unique and volatile sector gives MTSL and YOU the edge. Our insistence on thorough research and knowledge of the forces moving the sector minimize your downside risk while maximizing your potential for capital growth. You wont pay a fortune for MTSL either. Were making fresh company recommendations and providing more timely updates on breaking news than in the past. Its not a change in investment philosophybuying carefully selected biotech stocks and holding them long-term still promises the greatest return. But with more companies on our radar screen, a dynamic analyst team, and recommendations for long-term buying and short-selling stocks, theres a lot to the new MTSL.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access